Discover
BTAI
BioXcel Therapeutics, Inc.
1.37
2 x 1.01
2 x 1.77
bid
ask
-
0.04
2.84%
2 @ 04:00 AM
1.34 -0.03 (2.19%)
| Ytd | -14.37% | |
| 1y | -30.46% |
1.36
day range
1.42
1.01
52 week range
8.08
| Open | 1.38 | Prev Close | 1.41 | Low | 1.36 | High | 1.42 | Mkt Cap | 42.30M |
| Vol | 331.61K | Avg Vol | 762.13K | EPS | -4.77 | P/E | N/A | Forward P/E | -0.21 |
| Beta | 0.29 | Short Ratio | 0.93 | Inst. Own | 8.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-26 | 50-d Avg | 1.19 | 200-d Avg | 1.70 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 206.00K | ||
| Revenues (USD) | 206.00K | ||
| Cost of Revenue | 283.00K | ||
| Gross Profit | -77.00K | ||
| Operating Expenses | 10.15M | ||
| Research and Development Expense | 2.96M | ||
| Selling, General and Administrative Expense | 7.19M | ||
| Operating Income | -10.22M | ||
| Interest Expense | 4.20M | ||
| Net Income | -12.69M | ||
| Net Income Common Stock | -12.69M | ||
| Net Income Common Stock (USD) | -12.69M | ||
| Consolidated Income | -12.69M | ||
| Earnings per Basic Share | -0.54 | ||
| Earnings per Basic Share (USD) | -0.54 | ||
| Earnings per Diluted Share | -0.54 | ||
| Earning Before Interest & Taxes (EBIT) | -8.49M | ||
| Earning Before Interest & Taxes (USD) | -8.49M | ||
| Weighted Average Shares | 23.57M | ||
| Weighted Average Shares Diluted | 23.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.18M | ||
| Cash and Equivalents (USD) | 17.18M | ||
| Trade and Non-Trade Receivables | 216.00K | ||
| Current Assets | 33.91M | ||
| Property, Plant & Equipment Net | 117.00K | ||
| Total Assets | 34.03M | ||
| Debt Current | 22.43M | ||
| Total Debt | 100.29M | ||
| Current Liabilities | 54.99M | ||
| Debt Non-Current | 77.86M | ||
| Total Liabilities | 139.57M | ||
| Accumulated Retained Earnings (Deficit) | -732.78M | ||
| Shareholders Equity | -105.54M | ||
| Shareholders Equity (USD) | -105.54M | ||
| Assets Non-Current | 117.00K | ||
| Total Debt (USD) | 100.29M | ||
| Inventory | 500.00K | ||
| Liabilities Non-Current | 84.57M | ||
| Trade and Non-Trade Payables | 16.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 58.00K | ||
| Net Cash Flow from Financing | 232.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.58M | ||
| Issuance (Purchase) of Equity Shares | 8.34M | ||
| Issuance (Repayment) of Debt Securities | -8.11M | ||
| Net Cash Flow from Operations | -11.81M | ||
| Share Based Compensation | 435.00K | ||